TrialEuropean journal of haematology2014

Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France.

Jérôme Rey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.